CDX2 and colorectal cancer: While the diagnosis of colorectal cancer benefits from relatively sensitive and specific biomarkers indicating a CDX2 and CK7-/CK20+ phenotype, some colorectal cancers lack such typical molecular characteristics as exemplified by our samples from colorectal cancer metastases.